NO960550L - Metode for forhindring av nöytrofilformidlet bindevevsskade - Google Patents

Metode for forhindring av nöytrofilformidlet bindevevsskade

Info

Publication number
NO960550L
NO960550L NO960550A NO960550A NO960550L NO 960550 L NO960550 L NO 960550L NO 960550 A NO960550 A NO 960550A NO 960550 A NO960550 A NO 960550A NO 960550 L NO960550 L NO 960550L
Authority
NO
Norway
Prior art keywords
connective tissue
tissue damage
neutrophil mediated
preventing neutrophil
mediated connective
Prior art date
Application number
NO960550A
Other languages
English (en)
Norwegian (no)
Other versions
NO960550D0 (no
Inventor
Michael John Janusz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO960550D0 publication Critical patent/NO960550D0/no
Publication of NO960550L publication Critical patent/NO960550L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO960550A 1993-08-12 1996-02-12 Metode for forhindring av nöytrofilformidlet bindevevsskade NO960550L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10555793A 1993-08-12 1993-08-12
PCT/US1994/007696 WO1995005185A1 (en) 1993-08-12 1994-07-11 Method of preventing neutrophil mediated connective tissue damage

Publications (2)

Publication Number Publication Date
NO960550D0 NO960550D0 (no) 1996-02-12
NO960550L true NO960550L (no) 1996-02-12

Family

ID=22306496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960550A NO960550L (no) 1993-08-12 1996-02-12 Metode for forhindring av nöytrofilformidlet bindevevsskade

Country Status (13)

Country Link
US (1) US5384119A (enExample)
EP (1) EP0713394A1 (enExample)
JP (1) JPH09500903A (enExample)
KR (1) KR960703608A (enExample)
CN (1) CN1128952A (enExample)
AU (1) AU680284B2 (enExample)
CA (1) CA2168211A1 (enExample)
HU (1) HUT74581A (enExample)
IL (1) IL110616A0 (enExample)
NO (1) NO960550L (enExample)
TW (1) TW285641B (enExample)
WO (1) WO1995005185A1 (enExample)
ZA (1) ZA945938B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
DE1067212B (de) * 1956-06-04 1959-10-15 Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk Verfahren zur Herstellung von löslichen Polyharnstoffen
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
DE2162963C3 (de) * 1971-12-18 1979-02-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 1,4-Diaminobenzol-2,5-disulfonsäure
US3993625A (en) * 1973-05-28 1976-11-23 Toray Industries, Inc. Permselective polymeric membranes of organic polyamide or polyhydrazide
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
DE2516305A1 (de) * 1975-04-15 1976-10-28 Dynamit Nobel Ag Wasserdispergierbare esterharze
US4087548A (en) * 1976-05-10 1978-05-02 American Cyanamid Company Complement inhibitors
US4027038A (en) * 1976-05-10 1977-05-31 American Cyanamid Company Complement inhibitors
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
WO1980000151A1 (en) * 1978-07-03 1980-02-07 American Home Prod N-(3-alkylaminopropyl)-n'-phenylureas
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4724235A (en) * 1981-05-20 1988-02-09 A. H. Robins Company, Incorporated N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
DE3345902A1 (de) * 1983-12-20 1985-08-29 Cassella Ag, 6000 Frankfurt In wasser loesliche polymischester, verfahren zu ihrer herstellung und ihre verwendung
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
GB9014546D0 (en) * 1990-06-29 1990-08-22 Fujisawa Pharmaceutical Co Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
AU680284B2 (en) 1997-07-24
ZA945938B (en) 1995-03-16
HUT74581A (en) 1997-01-28
EP0713394A1 (en) 1996-05-29
CN1128952A (zh) 1996-08-14
IL110616A0 (en) 1994-11-11
NO960550D0 (no) 1996-02-12
US5384119A (en) 1995-01-24
TW285641B (enExample) 1996-09-11
WO1995005185A1 (en) 1995-02-23
HU9600305D0 (en) 1996-04-29
JPH09500903A (ja) 1997-01-28
AU7358694A (en) 1995-03-14
CA2168211A1 (en) 1995-02-23
KR960703608A (ko) 1996-08-31

Similar Documents

Publication Publication Date Title
FI952926L (fi) Menetelmät allergioiden hoitamiseksi tai ehkäisemiseksi
EP0772590A1 (en) Thrombin inhibitors
CA2155931A1 (en) Inhibitors of thrombosis
IT1295535B1 (it) Processo di polimerizzazione di vinilidenfluoruro (vdf)
GR3034208T3 (en) Human neutrophil elastase inhibitors
NO983688L (no) Serin-protease-inhibitorer
DE69620161D1 (de) Thrombininhibitoren
NO20005237L (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
ATE209191T1 (de) Parazinon thrombin inhibitoren
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
FI930405A7 (fi) Menetelmä loppusterilointia varten
FI944217A0 (fi) Substituoidut pipekoliinihappojohdannaiset HIV-proteaasin estäjinä
WO1999005096A3 (en) Urokinase inhibitors
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
HUT65140A (en) Process for producing elasteze- and catepsin-d-inhibitors
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE69625230D1 (de) Thrombininhibitoren
DE69604719D1 (de) Entfernung von Oligomeren aus im wesentlichen kristallinen Alpha-Olefinpolymeren
DE69609219D1 (de) Peroxycarbonsäureester Photoinitiatoren abgeleitet von Stickstoff-Heterozyklen
NO960550D0 (no) Metode for forhindring av nöytrofilformidlet bindevevsskade
AU1296795A (en) Methods for preventing or treating hiv-1 or hiv-2 infection
AU3475693A (en) Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist
IT1265209B1 (it) Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro
IT1294218B1 (it) Protezione contro le scariche elettriche per l'elettrodo neutro di apparecchi chirurgici ad alta frequenza
SE9303040D0 (sv) Användning av polymerbetong för framställning av profilerade byggnadselement för utnyttjande som kvarsittande formdelar vid betonggjutning